TARO-BORTEZOMIB POWDER FOR SOLUTION Kanada - İngilizce - Health Canada

taro-bortezomib powder for solution

taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 3.5mg - bortezomib (bortezomib mannitol boronic ester) 3.5mg - antineoplastic agents

TARO-BORTEZOMIB POWDER FOR SOLUTION Kanada - İngilizce - Health Canada

taro-bortezomib powder for solution

taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 2.5mg - bortezomib (bortezomib mannitol boronic ester) 2.5mg - antineoplastic agents

TARO-BORTEZOMIB POWDER FOR SOLUTION Kanada - İngilizce - Health Canada

taro-bortezomib powder for solution

taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 1mg - bortezomib (bortezomib mannitol boronic ester) 1mg - antineoplastic agents

Bortezomib-AFT Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

bortezomib-aft

aft pharmaceuticals ltd - bortezomib 3.5mg (as a mannitol boronic ester) - powder for injection - 3.5 mg - active: bortezomib 3.5mg (as a mannitol boronic ester) excipient: mannitol - bortezomib-aft, in combination with melphalan and prednisone, is indicated for the treatment of patients with previously untreated multiple myeloma, who are not suitable for high dose chemotherapy. bortezomib-aft, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib-aft is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.

Bortezomib Waverley 3.5 mg powder for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bortezomib waverley 3.5 mg powder for solution for injection

waverley pharma europe limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib

Bortezomib 1 mg powder for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bortezomib 1 mg powder for solution for injection

aspire pharma limited - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib

Bortezomib 3.5 mg powder for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bortezomib 3.5 mg powder for solution for injection

aspire pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib

Bortezomib medac 3.5 mg powder for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bortezomib medac 3.5 mg powder for solution for injection

medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib

Bortezomib 1 mg powder for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bortezomib 1 mg powder for solution for injection

european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib